Well certainly some assumptions alright, there will almost certainly be further dilution as they fund expansion, adding more shares to the register , PE is based on NPAT after taking into account depreciation and amortization etc....nothing unusual in the above being a startup with no income but needs to be factored in to the degree it can be when trying to speculate on a future shareprice..
Based on today's shares on offer $3 a share gives a MC of $3b without allowing any further dilution so don't hold your breath..the MC represents the value of a Company the shareprice is just a division of it.
Why pick a potential shareprice that may never be achieved and just settle for a higher shareprice going forward with the potential to supprise to the upside...
In the meantime the shareprice is 9.1c and we have yet to sort out permits and finance for phase 1...it's a great little Company with a large potential but let's not get ahead of ourselves...
Cheers Whisky
- Forums
- ASX - By Stock
- AGY
- GLOBAL X LIT ETF FUND TOTAL
AGY
argosy minerals limited
Add to My Watchlist
0.00%
!
3.4¢

GLOBAL X LIT ETF FUND TOTAL, page-127
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.50M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.037 |
10 | 29462 | 0.036 |
2 | 45571 | 0.035 |
8 | 424560 | 0.034 |
6 | 266240 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 150000 | 1 |
0.034 | 170625 | 3 |
0.035 | 133399 | 2 |
0.036 | 557554 | 4 |
0.037 | 516946 | 2 |
Last trade - 16.30pm 04/07/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online